Olr943 inhibitors are a class of chemical compounds designed to specifically target and inhibit the activity of the olfactory receptor 943 (Olr943). Olfactory receptors are a large family of G-protein-coupled receptors (GPCRs) involved in the detection of odor molecules, and Olr943 is one such receptor encoded by the Olr943 gene. These inhibitors function by binding to the active site or an allosteric site of the receptor, thereby preventing its activation by natural ligands. This inhibition can be highly selective, depending on the structure of the inhibitor and its affinity for Olr943, and it may involve a variety of chemical interactions such as hydrogen bonding, hydrophobic interactions, and van der Waals forces.
The design and synthesis of Olr943 inhibitors often involve structure-activity relationship (SAR) studies to optimize their binding affinity and specificity. These studies typically include the modification of chemical groups within the inhibitor molecule to enhance its interaction with Olr943, as well as the use of computational modeling to predict and analyze binding modes. Additionally, high-throughput screening methods may be employed to identify promising candidates from large libraries of chemical compounds. Once potential inhibitors are identified, further refinement and testing are conducted to ensure that they exhibit the desired properties, such as high potency and minimal off-target effects. Overall, the development of Olr943 inhibitors represents a sophisticated process that combines elements of organic chemistry, biochemistry, and molecular biology to achieve precise modulation of olfactory receptor activity.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $26.00 $119.00 $213.00 | 27 | |
Targets BCR-ABL and other tyrosine kinases, possibly affecting signaling pathways interacting with Olr943. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
Targets RAF kinase, VEGFR, and PDGFR, potentially affecting various signaling cascades related to Olr943. | ||||||
Nilotinib | 641571-10-0 | sc-202245 sc-202245A | 10 mg 25 mg | $209.00 $413.00 | 9 | |
Selectively inhibits BCR-ABL, possibly influencing signaling pathways that intersect with Olr943. | ||||||
Pazopanib | 444731-52-6 | sc-396318 sc-396318A | 25 mg 50 mg | $130.00 $182.00 | 2 | |
Inhibits VEGFR, PDGFR, and c-Kit, which could indirectly modulate signaling pathways related to Olr943. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $63.00 $114.00 $218.00 $349.00 | 74 | |
EGFR tyrosine kinase inhibitor, could impact signaling pathways associated with Olr943. | ||||||
Afatinib | 439081-18-2 | sc-364398 sc-364398A | 5 mg 10 mg | $114.00 $198.00 | 13 | |
Irreversible EGFR inhibitor, may alter signaling cascades that interact with Olr943. | ||||||
Ibrutinib | 936563-96-1 | sc-483194 | 10 mg | $156.00 | 5 | |
Inhibits Bruton's tyrosine kinase, potentially influencing pathways related to Olr943 activity. | ||||||
Osimertinib | 1421373-65-0 | sc-507355 | 5 mg | $86.00 | ||
EGFR inhibitor, might affect cellular signaling pathways associated with Olr943. | ||||||
Trametinib | 871700-17-3 | sc-364639 sc-364639A sc-364639B | 5 mg 10 mg 1 g | $114.00 $166.00 $947.00 | 19 | |
MEK inhibitor, could indirectly affect signaling relevant to Olr943's function. | ||||||
Lenvatinib | 417716-92-8 | sc-488530 sc-488530A sc-488530B | 5 mg 25 mg 100 mg | $182.00 $661.00 $1690.00 | 3 | |
Inhibits multiple tyrosine kinases, potentially impacting various pathways affecting Olr943. | ||||||